glutamic acid

CAS No. 56-86-0

glutamic acid ( Glutamic Acid; Glutamicol; AI3-18472 )

Catalog No. M18825 CAS No. 56-86-0

(S)-Glutamic acid acts as an excitatory transmitter, shows a direct activating effect on the release of DA from dopaminergic terminals.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    glutamic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    (S)-Glutamic acid acts as an excitatory transmitter, shows a direct activating effect on the release of DA from dopaminergic terminals.
  • Description
    Glutamic Acid is a non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.
  • Synonyms
    Glutamic Acid; Glutamicol; AI3-18472
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56-86-0
  • Formula Weight
    147.13
  • Molecular Formula
    C5H9NO4
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    C(CC(=O)O)C(C(=O)O)N
  • Chemical Name
    L-glutamic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Giorguieff MF, et al. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci Lett. 1977 Oct;6(1):73-7.
molnova catalog
related products
  • Fulvestrant

    Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast Y in post-menopausal women with disease progression following anti-estrogen therapy.

  • Ethisterone

    Ethisterone is a progestogen hormone being considered to treat prostate Y.

  • CMP8

    CMP8 is a selective ligand for estrogen receptor. CMP8 binds to the mutant estrogen receptor ligand binding domain (ERLBD).